Ó£ÌÒÊÓƵ

Focus on Tools for the Research, Drug Discovery and Cell Therapy Markets.

The European Patent Office (EPO) upholds Ó£ÌÒÊÓƵ's patent for its dual genomic safe harbour technology, opti-oxâ„¢, securing the bro...

Ó£ÌÒÊÓƵ's ioSensory Neurons pain research was selected for presentation at SfN’s Neuroscience 2024 press conference.

Ó£ÌÒÊÓƵ Wins Honours for Innovation in Synthetic Biology and Exceptional Business Growth.

Ó£ÌÒÊÓƵ appoints new Chief Financial Officer, Przemek Obloj

Ó£ÌÒÊÓƵ launches panel of 16 neurodegenerative disease models for research and drug discovery in Alzheimer’s and Parkinson’s disea...

Ó£ÌÒÊÓƵ launches ioAstrocytes, advancing how scientists can model the human brain.

Bi/ond and Ó£ÌÒÊÓƵ collaboration offers a significant advancement for DMD research and drug discovery.